SENS
NASDAQ · Health Care
Senseonics Holdings Inc
$7.43
+0.52 (+7.53%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 133.13M | 128.13M | 147.60M |
| Net Income | 20.15M | 18.56M | 19.98M |
| EPS | — | — | — |
| Profit Margin | 15.1% | 14.5% | 13.5% |
| Rev Growth | +16.8% | +23.2% | +7.4% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 129.56M | 136.42M | 140.63M |
| Total Equity | 192.75M | 187.59M | 191.92M |
| D/E Ratio | 0.67 | 0.73 | 0.73 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 29.07M | 33.80M | 33.57M |
| Free Cash Flow | 9.65M | 10.98M | 12.10M |